Daniel Pichl, Chief People Officer at SpringWorks Therapeutics (NASDAQ:SWTX), has recently sold a significant portion of his holdings in the company. According to a Form 4 filing with the SEC, Pichl ...
50mon MSN
Q2 2025 Management View CFO John Merrill emphasized the company's financial strategy, which includes growing recurring revenue, increasing profitability, and maintaining a solid cash balance of $28M, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback